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Abstract
Empowerment is usually defined as a process of promoting 
the sense of competence and control as a means of capaci-
tating individuals to improve their life conditions. The aim of 
this study was to describe the psychometric qualities of the 
Portuguese Rheumatic Disease Empowerment Scale (P-
RES-8), an 8-item measure of empowerment for patients 
with rheumatic disease. The study enrolled 81 patients with 
rheumatic diseases. Participants filled in the P-RES-8, the 
Portuguese validated version of the Medical Outcomes Sur-
vey Short Form-36 (MOS SF-36), and a questionnaire includ-
ing sociodemographic data and disease-related variables. 
To evaluate the dimensionality of the P-RES-8 scale, an ex-
ploratory factor analysis was conducted, and its reliability 
was assessed by Cronbach’s α. The validity of this measure 
was assessed by analyzing the correlations between em-
powerment, quality of life, and other relevant variables (edu-
cation level and illness duration). The P-RES-8 proved to be 
a reliable 1-dimensional measure of empowerment in pa-
tients with rheumatic disease (Cronbach’s α = 0.94). Empow-
erment was positively related to quality of life. Particularly, 
the findings showed positive associations between empow-
erment, assessed by the P-RES-8, and each of the 8 domains 
of the MOS SF-36. The associations were stronger for mental 
health and general health perception. The results also re-
vealed that empowerment is positively associated with a 
higher education and more years after the diagnosis. The 
findings provide support for the adequacy of the P-RES-8 as 
a measure of empowerment in patients with rheumatic dis-
ease. Moreover, empowerment showed to be an important 
variable in the assessment of patients’ quality of life.
© 2018 The Author(s). Published by S. Karger AG, Basel 
on behalf of NOVA National School of Public Health
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Avaliação do empowerment em pacientes com 
doença crónica: Qualidades psicométricas da Escala 
Portuguesa de Empowerment na Doença Reumática
Palavras chave
Empowerment na doença crónica · Doenças reumáticas · 
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Resumo
O empowerment é geralmente definido como um proces-
so de promoção da perceção de competência e de con-
trolo como forma de capacitar os indivíduos para melho-
rar suas condições de vida. O estudo teve como objetivo 
analisar as qualidades psicométricas da Escala Portugue-
sa de Empowerment na Doença Reumática (P-RES-8), uma 
medida constituída por 8 itens destinada a pacientes com 
doença reumática. O estudo envolveu 81 sujeitos com 
doenças reumáticas. Os participantes preencheram o P-
RES-8, a versão validada em português do Medical Out-
comes Survey Short Form-36 (MOS SF-36) e um question-
ário de avaliação de dados sociodemográficos e variáveis 
relacionadas com a doença. Para avaliar a estrutura di-
mensional da escala P-RES-8, foi realizada uma análise fa-
torial exploratória, e a sua consistência foi avaliada através 
do cálculo do alfa de Cronbach. A validade desta medida 
foi avaliada através da análise das correlações entre em-
powerment, qualidade de vida e outras variáveis rele-
vantes (nível de escolaridade e tempo de duração da 
doença). A P-RES-8 mostrou ser uma medida unidimen-
sional de empowerment em indivíduos com doença re-
umática com elevada consistência interna (alfa de Cron-
bach = 0.94). O empowerment mostrou estar positiva-
mente relacionado com o nível percecionado de qualidade 
de vida. Em particular, os resultados revelaram associa-
ções positivas entre o empowerment, avaliado pelo P-
RES-8, e cada um dos oito domínios do MOS SF-36. As as-
sociações foram de maior magnitude para a saúde mental 
e a perceção geral da saúde. Os resultados também reve-
laram que o empowerment se encontra positivamente as-
sociado com o nível de escolaridade dos doentes e com o 
número de anos após o diagnóstico. Os resultados for-
neceram suporte à adequação do P-RES-8 como medida 
de empowerment em pacientes com doença reumática, 
que revelou ser uma variável importante na avaliação da 
qualidade de vida dos pacientes.
© 2018 The Author(s). Published by S. Karger AG, Basel 
on behalf of NOVA National School of Public Health
Introduction
Empowerment is a widely used concept in many dis-
ciplines. Empowerment is defined as “a process, a mech-
anism by which people, organizations, and communities 
gain mastery over their affairs” [1]. One of the most fun-
damental dimensions of empowerment is self-efficacy 
which comprises the ideas of a sense of self-worth and 
believe in one’s capacities to manage and influence per-
sonal life situations [2, 3]. In fact, in health promotion, it 
is described as a process through which people get more 
control over decisions and actions that affect their health 
[4]. For a successful chronic disease management, pa-
tients need to make choices in order to accomplish their 
personal and health-related goals [5]. The empowerment 
approach highlights the importance of helping patients to 
think critically and make autonomous and informed de-
cisions about their condition by self-management [6]. Pa-
tients’ self-management implies being able to manage the 
symptoms, treatment, and physical and psychosocial 
consequences or lifestyle changes related to the chronic 
condition [7]. An empowerment approach is particularly 
appropriate in diseases such as diabetes [6], but also in 
rheumatic diseases, which can have a significant impact 
on patients’ physical, mental, and social life [8–12]. In 
rheumatology care, patient education is considered to be 
one way to reduce disability and to attain a better quality 
of life [13]. Hence, the goal of education is to empower 
patients so that they can manage their lives and their 
symptoms and live as independently as they can [14].
In recent years, a range of measures have been devel-
oped to assess health-related empowerment [15–17]. Based 
on an earlier work in diabetes education, Anderson et al. 
[18] developed the Diabetes Empowerment Scale (DES) in 
order to assess the psychosocial self-efficacy of patients 
with diabetes. The pilot version of the DES was a 37-item 
Likert-type questionnaire representing 8 conceptual di-
mensions: assessing the need for change, developing a 
plan, overcoming barriers, asking for support, supporting 
oneself, coping with emotion, motivating oneself, and 
making diabetes care choices appropriate for circumstanc-
es. This self-assessment questionnaire was then reduced to 
28 items containing 3 subscales: (1) managing the psycho-
social aspects of diabetes; (2) assessing dissatisfaction and 
readiness to change; and (3) setting and achieving diabetes 
goals [18]. Later, an 8-item short form of the DES (DES-SF) 
was created to briefly assess patients’ self-efficacy [19]. The 
authors chose the item with the highest item-to-subscale 
dimension correlation from each of the 8 original concep-
tual dimensions. This version demonstrated good evi-
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dence for reliability (α = 0.84) and validity [19]. In 2013, 
the DES-SF was translated and adapted to Portuguese and 
then applied to a sample of diabetic patients [20]. Cron-
bach’s α coefficient was found to be 0.87, and test-retest 
reliability ranged from 0.93 to 1.00.
Although created as an empowerment measure in dia-
betes care, the DES has been translated into different lan-
guages and used in patients with other chronic conditions 
(e.g., end-stage renal disease [21]), including rheumatic 
diseases [22]. A modified version of the DES-SF was cre-
ated in Korea (Health Empowerment Scale – K-HES), re-
placing the term “diabetes” by “health problems” and ex-
panding the items to cover all kinds of health conditions 
that affect the elderly [23]. We did not find any study that 
has adapted the DES-SF to rheumatic patients. 
Considering the lack of a Portuguese empowerment 
instrument for patients with rheumatic diseases, we de-
veloped the Portuguese Rheumatic Disease Empower-
ment Scale (P-RES-8), based on the already existing Por-
tuguese version of the DES-SF. Therefore, this study aims 
to determine the psychometric qualities of the P-RES-8, 
such as reliability and validity. First, to analyze construct 
validity of the instrument, an exploratory factor analysis 
was conducted to assess the scale’s dimensionality. The 
internal consistency of the measure was analyzed in order 
to determine its reliability. Then, the associations be-
tween empowerment and self-perceived health status 
(Medical Outcomes Survey Short Form-36; MOS SF-36) 
were calculated to analyze the validity of the P-RES-8. Fi-
nally, the correlation between empowerment and other 
variables (education and illness duration) was examined 




A total of 81 patients attending the Rheumatology Department 
at 2 public Portuguese hospitals were recruited for this cross-sec-
tional study. Eligible patients included those diagnosed with a 
rheumatic disease, over 18 years old, able to understand and an-
swer self-report questionnaires, and willing to participate in this 
study. The study protocol received the approval of both hospitals’ 
Ethics Committees, and written informed consent was obtained 
from patients who agreed to participate. All patients were diag-
nosed by a specialist and met the American College of Rheumatol-
ogy criteria for classification of a rheumatic disease.
Measures 
Written permission was obtained from the authors of the orig-
inal and Portuguese versions of the DES-SF to adapt the instru-
ment to rheumatic disease. The original scale was altered by 
changing the word “diabetes” to “rheumatic disease” in all items. 
The P-RES-8 is an 8-item Likert-type scale ranging from 1 (to-
tally disagree) to 5 (totally agree), and it is scored by averaging the 
scores of all completed items. Higher scores suggest a greater lev-
el of perception of empowerment. According to previous research 
[22], we reasoned that self-efficacy and control over the disease 
should be positively related to perceived quality of life. So, to es-
tablish validity and test correlations between P-RES-8 scores and 
patients’ self-perceived health status, the Portuguese validated 
version of the MOS SF-36 [24] questionnaire was used. This in-
strument measures the quality of life of the general population, 
and it is also applicable to patients with chronic diseases, since it 
evaluates the subjective perception concerning the impact of an 
underlying illness. Evidence has shown the MOS SF-36 to be a 
psychometrically valid measure to assess the quality of life in pa-
tients with rheumatic diseases [24, 25]. It includes 36 items cover-
ing the following 8 domains: physical functioning, physical per-
formance, bodily pain, general health, social functioning, emo-
tional well-being, mental health, and energy/fatigue. The scores 
obtained in each domain range from 0 to 100 with higher scores 
corresponding to higher levels of quality of life. Patients also filled 
in a questionnaire that included sociodemographic data and dis-
ease-related variables. 
Statistics 
All statistical analyses were calculated using SPSS software 
(IBM SPSS Statistics 23.0). To test the dimensionality of the P-
RES-8, an exploratory factor analysis was conducted. Kolmogorov-
Smirnov test results for each variable showed that normality of 
data was not assured (p < 0.000). As a result, nonparametric cor-
relation tests (Spearman rank order correlation) were used for all 
analyses. Statistical significance was considered as a p value of 
< 0.05.
Results
Patients had a mean age of 59.7 years (standard devia-
tion [SD] 12.24), ranging from 31 to 79 years, and 77.8% 
were women (n = 63). The majority were married or in a 
registered partnership (71.3%), 15% were widowed, and 
the remaining were either single or divorced. Most had 
less than 9 years of education (62%), and 16.5% had grad-
uated. Nearly half of the participants were retired (44.4%), 
27.2% were employed full time, and 14.8% were unem-
ployed. Rheumatic diagnoses were combined into the fol-
lowing groups, as proposed by the American Rheuma-
tism Association Nomenclature and Classification of Ar-
thritis and Rheumatism (1983) [26]: diffuse connective 
tissue diseases (50.6%), extraarticular disorders (24.7%, 
of which 22.2% were fibromyalgia), spondyloarthritis 
(11.1%), osteoarthritis (9.9%), neurovascular disorders 
(2.5%), and bone and cartilage disorders (1.2%). The 
mean illness duration of all patients was 8.67 years (SD 
9.24).
Portuguese Rheumatic Disease 
Empowerment Scale
69Port J Public Health 2018;36:66–71
DOI: 10.1159/000492084
Regarding the exploratory factor analysis results of the 
P-RES-8, the Kaiser-Mayer-Olkin index was 0.89, and 
Bartlett’s sphericity test was significant, χ2(28) = 499.64, 
p < 0.001, indicating the adequacy of the data for factor 
analytic procedures. The factorial free-extraction method 
was used, and a 1-factor solution was suggested by appli-
cation of the Scree test criterion. The 8-item scale of the 
measure, which comprised only 1 factor (eigenvalue = 
4.96), explained 62.04% of the total variance. Factor load-
ings and item communalities, after the exploratory factor 
analysis, are presented in Table 1.
All the factor loadings obtained are higher than 0.50, 
and the communalities are also satisfactory for all the 8 
items of the scale. Internal consistency was high (Cron-
bach’s α = 0.94). Cronbach’s α values, if the item was de-
leted, varied between 0.91 (item 08) and 0.93 (item 01). 
All inter-item correlations were significant (p < 0.001) 
and varied between 0.36 and 0.83. The frequencies and 
descriptive statistics (mean, SD, skewness, and kurtosis) 
of the responses to each of the items of the P-RES-8 are 
presented in Table 2. The results show an acceptable vari-
ability of response distribution to the scale items.
Table 3 exhibits the means, SDs, and intercorrelation 
matrix for empowerment and MOS SF-36 dimensions. 
The mean scores of the MOS SF-36 are below 65% for all 
domains of this instrument. Therefore, the quality of life 
assessed by the MOS SF-36 is revealed to be relatively low, 
in particular in the bodily pain domain (mean 32.63). The 
empowerment measure P-RES-8 is positively and signifi-
cantly related to all the domains of quality of life, and all 
the correlations are above 0.25. Particularly, the associa-
tions are stronger for mental health (rs = 0.44, p < 0.001) 
and general health perception (rs = 0.40, p < 0.001). Con-
sidering the correlations between MOS SF-36 dimen-
sions, the results show weak to moderate, significant and 
positive associations between all variables, as expected by 
the authors of the Portuguese version of the instrument 
[27]. Moreover, significant positive associations were also 
obtained between empowerment and component sum-
mary scores of mental (rs = 0.36, p = 0.001) and physical 
functioning (rs = 0.23, p = 0.043). Finally, associations 
between empowerment and individual variables (pa-
tients’ education and years after diagnosis) were ana-
lyzed. Results showed that empowerment is positively as-
sociated with years of education (rs = 0.29, p = 0.009) and 
years after diagnosis (rs = 0.29, p = 0.009).
Discussion
The main purpose of this study was to provide support 
for the psychometric qualities of an empowerment mea-
sure for patients with rheumatic diseases. Participants in 
this study were mostly women, middle-aged, married, 
and with a low level of education. The obtained results 
showed relatively low scores for all the domains of the 
MOS SF-36, and pain was considered the most important 
domain limiting quality of life, as suggested by previous 
research [28].
The construct validity of the P-RES-8 was confirmed 
because the 1-factor structure of the P-RES-8 scale was 
obtained, in accordance with previous studies using this 
health-related empowerment measure [19, 20, 23]. More-
over, internal consistency of the instrument was high. 
The criterion validity of the P-RES-8 was supported by 
the direction and significance of the associations found 
between patient empowerment and quality of life, also 
described in other studies with patients with rheumatic 
disease [22]. In fact, empowerment was positively associ-
ated with all dimensions of patients’ quality of life, which 
means that, as the sense of control in disease management 
increases, so does patients’ perception of their quality of 
life. Particularly, patients’ empowerment was moderately 
associated with the domains of mental health and general 
health. This result highlights the importance of patients’ 
perception of their own power and control over the dis-
ease in the appraisal of general health and psychological 
state. 
Additional evidence for the validity of the P-RES-8 is 
sustained by the correlations between empowerment and 
other relevant variables. Specifically, higher levels of em-
powerment were reported by patients with a higher edu-
cation, which was also found in the study by Anderson et 




08 Get to know each other to make the best
choices 0.91 0.83
05 Dealing positively with the disease 0.89 0.80
07 Be motivated to take care of the disease 0.89 0.78
04 Feeling better about the disease 0.84 0.71
06 Ask for help to treat the disease 0.80 0.63
02 Achieve goals related to the disease 0.72 0.52
03 Find alternative ways to overcome problems 0.64 0.41
01 Identify the care you take with the disease 0.54 0.29
h2 indicates communalities after factor extraction.
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al. [18] on patients with diabetes. Moreover, empower-
ment levels were positively correlated with the duration 
of the disease. This finding may be explained by the in-
creasing use of more adaptive illness-related coping strat-
egies over time, which contributes to a perception of 
greater control over the disease. 
This study has some limitations that should be taken 
into consideration when interpreting the results. First, 
this is a cross-sectional and correlational study which al-
lows us to draw conclusions from the associations be-
tween variables but not concerning cause-effect relations. 
Also, the representativeness of the sample can be ques-
tioned due to its size, type (convenience sample), recruit-
ment hospitals, and demographic characteristics (e.g., 
gender, age, and education). Finally, the sample compris-
es several rheumatic diagnoses with different symptoms 
and impacts on patients’ quality of life. Nonetheless, to 
minimize the disadvantages of using small samples in 
scale development, we intended to maximize the sample 
size, particularly to ensure the variance of data conditions 
[29]. Further studies with other groups of rheumatic dis-
eases, including 1-disease samples, are required to con-
firm the factor structure and reliability of the scale. Also, 
future studies should consider analyzing test-retest reli-
ability to assess how constant scores remain from one oc-
casion to another [29]. Despite these limitations, as previ-
ously stated, the main purpose of this research was to 
study the psychometric qualities of the P-RES-8, and the 
results are adequate to conclude on the validity and fidel-
ity of this measure. Furthermore, the results obtained are 
consistent with other empirical findings reinforcing the 
validity of the P-RES-8 scale in assessing the sense of em-
powerment in rheumatic patients.
Conclusion
Empowerment is recognized as a significant outcome 
of effective health-care interventions in chronic disease 
[17, 30, 31] as well as an important indicator of patients’ 
Table 2. Descriptive statistics and frequency of responses to the P-RES-8 (n = 81)










Item 01 3.15±1.61 –0.23 –1.59 27.2 12.3 7.4 24.7 28.4
Item 02 3.02±1.49 –0.09 –1.52 22.2 22.2 6.2 29.6 19.8
Item 03 2.91±1.47 0.01 –1.45 24.7 19.8 12.3 25.9 17.3
Item 04 3.30±1.55 –0.39 –1.44 21.0 16.0 3.7 30.9 28.4
Item 05 3.40±1.54 –0.57 –1.24 22.2 8.6 6.2 33.3 29.6
Item 06 3.43±1.60 –0.57 –1.32 23.5 8.6 3.7 29.6 34.6
Item 07 3.27±1.57 –0.39 –1.45 23.5 12.3 6.2 29.6 28.4
Item 08 3.22±1.70 –0.26 –1.70 28.4 13.6 1.2 21.0 35.8
Table 3. Empowerment (P-RES-8) and quality of life (MOS SF-36): descriptive statistics and nonparametric correlations (n = 82)
Mean ± SD 1 2 3 4 5 6 7 8 9
1 Empowerment (P-RES-8) 3.21±1.27 –
2 Physical functioning 60.17±26.25 0.23* –
3 Physical performance 59.95±35.32 0.24* 0.39*** –
4 Bodily pain 32.53±19.16 0.27* 0.44*** 0.38*** –
5 General health 42.49± 19.44 0.40*** 0.44*** 0.41*** 0.36** –
6 Social functioning 60.19±29.59 0.33** 0.39*** 0.28* 0.43*** 0.37** –
7 Emotional well-being 58.23±34.09 0.30** 0.35** 0.71*** 0.40*** 0.38** 0.34** –
8 Mental health 50.62±24.29 0.44*** 0.28* 0.32** 0.30** 0.34** 0.49*** 0.44*** –
9 Energy/fatigue 40.43±22.52 0.26* 0.48*** 0.39*** 0.47*** 0.48*** 0.35** 0.45*** 0.41*** –
* p < 0.05. ** p < 0.01. *** p < 0.001.
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self-management and adjustment to disease. This study 
provides preliminary support for the validity and reliabil-
ity of the P-RES-8 as a measure of perception of empow-
erment in patients with rheumatic diseases. Further stud-
ies are needed to ensure that the instrument is appropri-
ate to assess the efficacy of health education programs.
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